These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 26184999

  • 21. Inhibition of the signal transducers and activators of transcription (STAT) 3 signalling pathway by AG490 in laryngeal carcinoma cells.
    Zhang H, Zhang D, Luan X, Xie G, Pan X.
    J Int Med Res; 2010; 38(5):1673-81. PubMed ID: 21309481
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells.
    Nielsen M, Kaestel CG, Eriksen KW, Woetmann A, Stokkedal T, Kaltoft K, Geisler C, Röpke C, Odum N.
    Leukemia; 1999 May; 13(5):735-8. PubMed ID: 10374878
    [Abstract] [Full Text] [Related]

  • 23. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
    Iwamaru A, Szymanski S, Iwado E, Aoki H, Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, Kondo S, Priebe W, Kondo Y.
    Oncogene; 2007 Apr 12; 26(17):2435-44. PubMed ID: 17043651
    [Abstract] [Full Text] [Related]

  • 24. Tyrosine kinase inhibitor tyrphostin AG490 reduces liver injury in LPS-induced shock.
    Gyurkovska V, Ivanovska N.
    Eur J Pharmacol; 2015 Mar 15; 751():118-26. PubMed ID: 25666385
    [Abstract] [Full Text] [Related]

  • 25. Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death.
    Granato M, Gilardini Montani MS, Santarelli R, D'Orazi G, Faggioni A, Cirone M.
    J Exp Clin Cancer Res; 2017 Nov 28; 36(1):167. PubMed ID: 29179721
    [Abstract] [Full Text] [Related]

  • 26. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
    Ferrajoli A, Faderl S, Van Q, Koch P, Harris D, Liu Z, Hazan-Halevy I, Wang Y, Kantarjian HM, Priebe W, Estrov Z.
    Cancer Res; 2007 Dec 01; 67(23):11291-9. PubMed ID: 18056455
    [Abstract] [Full Text] [Related]

  • 27. STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.
    Holtick U, Vockerodt M, Pinkert D, Schoof N, Stürzenhofecker B, Kussebi N, Lauber K, Wesselborg S, Löffler D, Horn F, Trümper L, Kube D.
    Leukemia; 2005 Jun 01; 19(6):936-44. PubMed ID: 15912144
    [Abstract] [Full Text] [Related]

  • 28. Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2.
    Sakamoto E, Hato F, Kato T, Sakamoto C, Akahori M, Hino M, Kitagawa S.
    J Leukoc Biol; 2005 Jul 01; 78(1):301-9. PubMed ID: 15845643
    [Abstract] [Full Text] [Related]

  • 29. Tyrosine kinase inhibitor AG490 inhibits the proliferation and migration and disrupts actin organization of cancer cells.
    Kamran MZ, Patil P, Shirsath K, Gude RP.
    J Environ Pathol Toxicol Oncol; 2013 Jul 01; 32(4):361-71. PubMed ID: 24579787
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of heat shock protein response enhances PS-341-mediated glioma cell death.
    Liu Y, Zheng T, Zhao S, Liu H, Han D, Zhen Y, Xu D, Wang Y, Yang H, Zhang G, Wang C, Wu J, Ye Y.
    Ann Surg Oncol; 2012 Jul 01; 19 Suppl 3():S421-9. PubMed ID: 21732139
    [Abstract] [Full Text] [Related]

  • 31. The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells.
    Lu K, Chen N, Zhou XX, Ge XL, Feng LL, Li PP, Li XY, Geng LY, Wang X.
    Biochem Biophys Res Commun; 2015 Aug 14; 464(1):292-8. PubMed ID: 26116769
    [Abstract] [Full Text] [Related]

  • 32. Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress.
    Uckun F, Ozer Z, Vassilev A.
    Br J Haematol; 2007 Feb 14; 136(4):574-89. PubMed ID: 17367410
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tyrosine kinase inhibitor Thiotanib targets Bcr-Abl and induces apoptosis and autophagy in human chronic myeloid leukemia cells.
    Fan J, Dong X, Zhang W, Zeng X, Li Y, Sun Y, Wang S, Wang Z, Gao H, Zhao W, Ju D.
    Appl Microbiol Biotechnol; 2014 Dec 14; 98(23):9763-75. PubMed ID: 25200837
    [Abstract] [Full Text] [Related]

  • 37. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.
    Lu K, Fang XS, Feng LL, Jiang YJ, Zhou XX, Liu X, Li PP, Chen N, Ding M, Wang N, Zhang J, Wang X.
    Cancer Lett; 2015 Apr 10; 359(2):250-8. PubMed ID: 25636517
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
    Gariboldi MB, Ravizza R, Molteni R, Osella D, Gabano E, Monti E.
    Cancer Lett; 2007 Dec 18; 258(2):181-8. PubMed ID: 17920763
    [Abstract] [Full Text] [Related]

  • 39. [Inhibitory effect of AG490 on invasion and metastasis of human pancreatic cancer cells in vitro].
    Huang C, Qiu ZJ, Cao J, Huang KJ, Zhang F, Jiang T, Zhu L, Liu J.
    Zhonghua Zhong Liu Za Zhi; 2006 Dec 18; 28(12):890-3. PubMed ID: 17533737
    [Abstract] [Full Text] [Related]

  • 40. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.